These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 171306)

  • 1. Toxic and reactogenic properties of pertussis bacteria (experimental and clinical studies).
    Demina AA; Semina NA; Trofimova NP; Igonina YA; Gracheva AM
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(3):293-304. PubMed ID: 171306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS; Malivanova OM; Sokolovskaya AD; Shavrova EN; Kapustik LA
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):439-48. PubMed ID: 7320507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative characteristics of the toxic properties of the whooping cough microbes].
    Chuprinina RP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):111-6. PubMed ID: 173120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on toxicity of Bordetella pertussis cultures and antigens.
    Spasojević V
    Dev Biol Stand; 1977; 34():197-205. PubMed ID: 190070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity testing of pertussis vaccines: effect of increased sensitivity of mice to Bordetella pertussis.
    Cameron J; Desormeaux Y; De Bellefeuille ML; Leclerc J
    J Biol Stand; 1984 Jan; 12(1):19-24. PubMed ID: 6321509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative pathomorphologic study of the toxic properties of a corpuscular pertussis vaccine and of a cell-free pertussis preparation].
    Grigor'eva LV; Ozeretskovskaia MN; Chigirinskiĭ AE; Koval'skaia SIa; Bazhanova IG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):52-7. PubMed ID: 2555983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis serotype of clinical isolates in Sweden during 1970-1995 and influence of vaccine efficacy studies.
    Tiru M; Askelöf P; Granström M; Hallander H
    Dev Biol Stand; 1997; 89():239-45. PubMed ID: 9272356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxicity of Bordetella pertussis suspensions associated with the preparation of pertussis vaccine].
    Raĭkher LI; Kalinina ES; Shafran MI; Khazina EKh; Aĭnbinder ZTs
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):15-7. PubMed ID: 6303021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Properties of an acellular preparation of Bordetella pertussis and its analysis after centrifugation in saccharose gradient].
    Letowska I; Kaczurba E; Schiller B
    Med Dosw Mikrobiol; 1993; 45(3):289-94. PubMed ID: 8189799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants.
    Knuf M; Schmitt HJ; Wolter J; Schuerman L; Jacquet JM; Kieninger D; Siegrist CA; Zepp F
    J Pediatr; 2008 May; 152(5):655-60, 660.e1. PubMed ID: 18410769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine.
    Scheifele DW; Bjornson G; Halperin SH; Mitchell L; Boraston S
    CMAJ; 1994 Jan; 150(1):29-35. PubMed ID: 8275406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
    Hormozi K; Parton R; Coote J
    Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis vaccine: reactivity in animal and man.
    Mebel S; Rustenbach S; Giese H; Winkler C; Thilo W
    Dev Biol Stand; 1977; 34():207-11. PubMed ID: 838145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempts at analysis of toxicity of pertussis vaccine. I. Body weight-decreasing toxicity in mice.
    Kurokawa M; Ishida S; Iwasa S; Asakawa S; Kuratsuka K
    Jpn J Med Sci Biol; 1968 Apr; 21(2):137-53. PubMed ID: 4299576
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test.
    Horiuchi Y; Takahashi M; Asada S; Ishida S
    Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse breeds and the toxicity test for pertussis vaccine.
    Pittman M
    Dev Biol Stand; 1980; 45():129-35. PubMed ID: 7399144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C; Xing D; Douglas A; Corbel M
    Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.